Been hesitant to do Rituxamib because we have found almost all CFS/ME patients have abnormally low CD19/CD20 cells, so not sure if want to lower them even more??
I am trying to make sense of this argument - it doesn't seem logical. Either RTX is a valid treatment in which case b cell depletion is required or it isn't a valid treatment.